Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
922
datasets available to search
ShareScore release 0.9.0
Dataset results
922 results for “Chronic lymphocytic leukemia”
Vorinostat and Decitabine in Treating Patients With Advanced Solid Tumors or Relapsed or Refractory Non-Hodgkin's Lymphoma, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, or Chronic Myelogenous L
ClinicalTrials.gov study NCT00275080. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Mechanisms of Idelalisib-Associated Diarrhea in Patients With Relapsed Chronic Lymphocytic Leukemia, Indolent Non-hodgkin Lymphoma, or Small Lymphocytic Lymphoma
ClinicalTrials.gov study NCT02928510. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Trial of GS-9219 in Chronic Lymphocytic Leukemia (CLL), Non-Hodgkin's Lymphoma (NHL) or Multiple Myeloma (MM)
ClinicalTrials.gov study NCT00499239. IPD Sharing: Not stated. Countries: 3. Publications: 0.
Phase 1B- Open Label Dose-Ranging Study of Oral AFX-2 in Adults With Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT01456182. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Oral Clofarabine in Chronic Lymphocytic Leukemia (CLL)
ClinicalTrials.gov study NCT00800566. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Obinutuzumab(GA101) in Combination With High-Dose Methylprednisolone(HDMP) in Chronic Lymphocytic Leukemia(CLL) Patients (GA101 & HDMP)
ClinicalTrials.gov study NCT02229422. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase I/II Trial of Idiotypic Vaccination for Chronic Lymphocytic Leukemia Using a Genetic Approach
ClinicalTrials.gov study NCT00038415. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Tafasitamab and Zanubrutinib for the Treatment of Patients With Newly Diagnosed Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma, TaZA CLL Study
ClinicalTrials.gov study NCT05718869. IPD Sharing: Not stated. Countries: 1. Publications: 0.
CD19-specific T-cell for Chronic Lymphocytic Leukemia (CLL)
ClinicalTrials.gov study NCT01653717. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Evaluation of Safety and Efficacy of Fludarabine, Cyclophosphamide, and Rituximab (FCR) +/- Lumiliximab in Subjects With Previously Untreated Chronic Lymphocytic Leukemia (CLL)
ClinicalTrials.gov study NCT00801060. IPD Sharing: Not stated. Countries: 8. Publications: 0.
A Phase 1-2, Multicenter, Open-Label Study of AEG35156 in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia and Indolent B-Cell Lymphomas
ClinicalTrials.gov study NCT00768339. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Trial of Bendamustine, Lenalidomide and Rituximab in Chronic Lymphocytic Leukemia (CLL) and Non-Hodgkin's Lymphoma (NHL)
ClinicalTrials.gov study NCT00864942. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Epirubicin and Rituximab in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT00062296. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of ABT-263 in Combination With Dose-Intensive Rituximab, or Dose-Intensive Rituximab Alone, in Previously Untreated Patients With B-Cell, Chronic Lymphocytic Leukemia (CLL)
ClinicalTrials.gov study NCT01087151. IPD Sharing: Not stated. Countries: 12. Publications: 0.
Protocol to Obtain Blood for Discovery of Novel Biomarkers and Potential Therapeutic Targets in Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT01069432. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Clinical Outcomes of Chronic Lymphocytic Leukemia (CCL) and Mantle Cell Lymphoma (MCL) Participants Treated With Ibrutinib: A Medical Chart Review From India
ClinicalTrials.gov study NCT03476655. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Ibrutinib or Idelalisib in Treating Patients With Persistent or Relapsed Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or Non-Hodgkin Lymphoma After Donor Stem Cell Transplant
ClinicalTrials.gov study NCT02662296. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Bendamustine Versus Fludarabine in Chronic Lymphocytic Leukemia (CLL)
ClinicalTrials.gov study NCT01423032. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of GNC-035 in Relapsed or Refractory Chronic Lymphocytic Leukemia and Other Hematological Malignancies
ClinicalTrials.gov study NCT05944978. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Observational Study: Safety and Effectiveness of Obinutuzumab in Chronic Lymphocytic Leukemia in Argentina
ClinicalTrials.gov study NCT03059251. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.